Dial-in numbers for the conference call are:
US: 1-877-704-4453
International: 1-201-389-0920
Individuals may register for the webcast at the following link:
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study
March 16, 2026
8:00 am
ET